A Randomised Controlled Clinical Trial of the Efficacy of HAART Intensification With Raltegravir in HIV Virally Suppressed Patients With Cognitive Impairment
Phase of Trial: Phase IV
Latest Information Update: 29 Jun 2016
At a glance
- Drugs Raltegravir (Primary) ; Antiretrovirals
- Indications HIV infections
- Focus Therapeutic Use
- Acronyms HANDral
- 15 Jan 2014 Planned End Date changed to 1 Oct 2013 as reported in ClinicalTrials.gov record.
- 15 Jan 2014 Status changed from not yet recruiting to discontinued as reported in ClinicalTrials.gov record.
- 10 Oct 2011 New trial record